Jane Street
PBE icon

Jane Street’s Invesco Biotechnology & Genome ETF PBE Stock Holding History

Jane Street’s Portfolio PBE Stock Details PBE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-4,221
Closed -$295K – 10252
2024
Q3 		$295K Buy
+4,221
New +$292K ﹤0.01% 8062
2020
Q2 		– Sell
-12,217
Closed -$568K – 7436
2020
Q1 		$568K Buy
12,217
+5,548
+83% +$289K ﹤0.01% 3490
2019
Q4 		$372K Sell
6,669
-78
-1% -$4.07K ﹤0.01% 4033
2019
Q3 		$320K Sell
6,747
-10,971
-62% -$562K ﹤0.01% 4099
2019
Q2 		$948K Buy
+17,718
New +$919K ﹤0.01% 2768
2018
Q3 		– Sell
-11,791
Closed -$645K – 5548
2018
Q2 		$645K Sell
11,791
-3,055
-21% -$155K ﹤0.01% 3297
2018
Q1 		$731K Buy
14,846
+7,650
+106% +$390K ﹤0.01% 3034
2017
Q4 		$339K Buy
7,196
+2,064
+40% +$96.7K ﹤0.01% 3619
2017
Q3 		$256K Buy
+5,132
New +$243K ﹤0.01% 3868
2017
Q1 		– Sell
-12,900
Closed -$501K – 4540
2016
Q4 		$501K Sell
12,900
-2,377
-16% -$96K ﹤0.01% 2862
2016
Q3 		$641K Sell
15,277
-1,008
-6% -$41.4K ﹤0.01% 2492
2016
Q2 		$602K Buy
16,285
+8,324
+105% +$326K ﹤0.01% 2572
2016
Q1 		$305K Sell
7,961
-23,608
-75% -$917K ﹤0.01% 3181
2015
Q4 		$1.59M Sell
31,569
-4,880
-13% -$241K 0.01% 1277
2015
Q3 		$1.67M Buy
+36,449
New +$2.04M 0.01% 1152
2015
Q2 		– Sell
-44,647
Closed -$2.46M – 3924
2015
Q1 		$2.46M Buy
+44,647
New +$2.41M 0.02% 741
2014
Q3 		– Sell
-5,418
Closed -$237K – 2920
2014
Q2 		$237K Sell
5,418
-97,653
-95% -$3.96M ﹤0.01% 2057
2014
Q1 		$4.29M Buy
+103,071
New +$4.41M 0.05% 280

Other funds holding PBE

GKWIM
Gerber Kawasaki Wealth & Investment Management Santa Monica, California $3.14B AUM 22.62% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
YIA
YHB Investment Advisors West Hartford, Connecticut $1.56B AUM 27.39% 1-Year Est. Return

Jane Street's PBE Position: Q4 2024 in Review

Jane Street sold out of Invesco Biotechnology & Genome ETF (PBE) in Q4 2024, closing a stake of 4,221 shares — an estimated $295K sold.

Jane Street first reported a position in PBE in Q1 2014 and held it in 18 quarters. The position peaked at $4.29M in Q1 2014. 96 funds tracked by Wall St. Rank hold PBE as of Q4 2024.

  • Jane Street reported no remaining Invesco Biotechnology & Genome ETF position as of Q4 2024 after selling out during the quarter.
  • Jane Street sold 4,221 Invesco Biotechnology & Genome ETF shares in Q4 2024, an estimated $295K.
  • Jane Street first reported a position in Invesco Biotechnology & Genome ETF in Q1 2014 and held it in 18 quarters.
  • Jane Street's Invesco Biotechnology & Genome ETF position peaked at $4.29M in Q1 2014.
  • 96 funds tracked by Wall St. Rank held Invesco Biotechnology & Genome ETF as of Q4 2024.

Based on Jane Street's 13F filing for Q4 2024, filed 14 Feb 2025.